Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

This week, we have an update on the latest incarnation of the SAFE Banking Act. We look at the legalization signature drive in Ohio. We note that New Jersey has eliminated its version of 280E. And finally, Jack in the Box is partnering with WeedMaps.

Continue Reading The Week in Weed: May 12, 2023

Welcome back to The Year In Weed, our annual roundup of cannabis-related stories.  As usual, we’ll adopt Dave Barry’s Year in Review format and look at stories month by month.  Last year, I hoped 2022 would provide some answers to the questions of 2021 and predicted we’d spend much of the year discussing ballot initiatives. Was I right? Well, you tell me…

Continue Reading The Year in Weed: 2022 Edition

As previously reported here, on February 22, 2021, New Jersey Governor Phil Murphy signed the “New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act” (CREAMMA), which amended the New Jersey Constitution to legalize recreational cannabis.

The law allows employers to conduct numerous forms of drug testing for cannabis, but limits an employer’s ability to rely on a positive cannabis test result in making employment decisions. It requires that a drug test include both “scientifically reliable objective testing methods and procedures, such as testing of blood, urine, or saliva” and a “physical evaluation.” The “physical evaluation” must be conducted by an individual certified to provide an opinion about an employee’s state of impairment, or lack of impairment, related to the use of cannabis. The law tasked the Cannabis Regulatory Commission with adopting standards for this “Workplace Impairment Recognition Expert” (WIRE), who must be trained to detect and identify an employee’s use or impairment from cannabis or other intoxicating substances and to assist in the investigation of workplace accidents.

Continue Reading New Jersey Cannabis Regulatory Commission Issues Guidance on “Workplace Impairment” Determinations

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

This week, the House of Representatives moves closer to voting on the MORE Act.  Meanwhile, in the Senate, a bill on cannabis research makes its way through the process.  In state news, New Jersey’s dispensary licenses and sales bring controversy.  On
Continue Reading The Week in Weed: April 1, 2022

As previously reported here, on February 22, 2021, New Jersey Governor Phil Murphy signed A21, the “New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act” (CREAMMA), which is enabling legislation for the amendment to the New Jersey Constitution making lawful the recreational use of marijuana in the state.

While the new law, among other things, allows employers to
Continue Reading New Jersey Cannabis Regulatory Commission’s “Personal Use Cannabis Rules” Do Not Provide Guidance About Employer Drug Testing Practices

New Jersey recently enacted a law permitting personal, nonmedical use of marijuana for individuals age 21 and over. Separate laws decriminalize marijuana and hashish possession and set out the penalties when individuals under age 21 use or possess marijuana or hashish. Although not immediately enforceable, New Jersey employers should immediately assess the implications of the laws on their current policies


Continue Reading New Jersey Recreational Marijuana Law Provides Significant Employment Protections to Marijuana Users

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

New Jersey (finally) passes a legalization bill.  South Dakota and Montana continue to struggle with implementing the will of the voters.  North Dakota, on the other hand, moves forward with legislation to allow adult-use cannabis.  On the federal level, members of
Continue Reading The Week in Weed: February 26, 2021